Therapeutic interventions using a combination of Telmisartan and omega 3-fatty acids in sodium arsenite-induced vascular endothelial dysfunction in rats: Modulation through ATP-sensitive K+ channels and eNOS

Journal of Complementary and Integrative Medicine

Volumn 12, Issue 2, 2015, Pages 143-151

  Nirwane, Abhijit ^a   Pawar, Vivek ^a   Majumdar, Anuradha ^a  

^a BOMBAY COLLEGE OF PHARMACY   (India)

Author keywords

diet drug therapy; nitric oxide; omega 3 fatty acids; Telmisartan; vascular endothelial dysfunction

Indexed keywords

ACETYLCHOLINE; ADENOSINE TRIPHOSPHATE SENSITIVE POTASSIUM CHANNEL; ARSENITE SODIUM; CHOLESTEROL; ENDOTHELIAL NITRIC OXIDE SYNTHASE; GLIBENCLAMIDE; GLUTATHIONE; N(G) NITROARGININE METHYL ESTER; NITRATE; NITRITE; OMEGA 3 FATTY ACID; SUPEROXIDE DISMUTASE; TELMISARTAN; THIOBARBITURIC ACID REACTIVE SUBSTANCE; TRIACYLGLYCEROL; ARSENOUS ACID DERIVATIVE; BENZIMIDAZOLE DERIVATIVE; BENZOIC ACID DERIVATIVE; CARDIOVASCULAR AGENT; NOS3 PROTEIN, RAT; SODIUM DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD VESSEL REACTIVITY; CHOLESTEROL BLOOD LEVEL; COMBINATION CHEMOTHERAPY; CONTROLLED STUDY; DRUG EFFECT; ENDOTHELIAL DYSFUNCTION; ENZYME ACTIVITY; LIPID BLOOD LEVEL; MALE; MONOTHERAPY; NONHUMAN; OXIDATIVE STRESS; RAT; VASCULAR ENDOTHELIUM; ANIMAL; BLOOD; CHEMICALLY INDUCED; DRUG EFFECTS; METABOLISM; PATHOPHYSIOLOGY; THORACIC AORTA; VASCULAR DISEASES; VASODILATATION; WISTAR RAT;

ANIMALS; AORTA, THORACIC; ARSENITES; BENZIMIDAZOLES; BENZOATES; CARDIOVASCULAR AGENTS; CHOLESTEROL; ENDOTHELIUM, VASCULAR; FATTY ACIDS, OMEGA-3; GLYBURIDE; KATP CHANNELS; MALE; NG-NITROARGININE METHYL ESTER; NITRIC OXIDE SYNTHASE TYPE III; OXIDATIVE STRESS; RATS, WISTAR; SODIUM COMPOUNDS; THIOBARBITURIC ACID REACTIVE SUBSTANCES; TRIGLYCERIDES; VASCULAR DISEASES; VASODILATION;

EID: 84929583486     PISSN: None     EISSN: 15533840     Source Type: Journal    
DOI: 10.1515/jcim-2015-0009     Document Type: Article

References (50)

1. Rubanyi GM. The role of endothelium in cardiovascular homeostasis and diseases. J Cardiovasc Pharmacol 1993;22:S1-14.
2. Stamler JS, Lamas S, Fang FC. Nitrosylation. The prototypic redox-based signaling mechanism. Cell 2001;106:675-83.
3. Avogaro A, Albiero M, Menegazzo L, de Kreutzenberg S, Fadini GP. Endothelial dysfunction in diabetes the role of reparatory mechanisms. Diabetes Care 2011;34:S285-90.
4. Lnt J. Characteristics of environmental geochemistry in the arseniasis area of the inner Mongolia of China. Sci Geogr Sin 1999;19:135-9.
5. Chiou HY, Chiou ST, Hsu YH, Chou YL, Tseng CH, Wei ML, Chen CJ. Incidence of transitional cell carcinoma and arsenic in drinking water: a follow-up study of 8,102 residents in an arseniasis-endemic area in northeastern Taiwan. Am J Epidemiol 2001;153:411-18.
6. Rahman MM, Mandal BK, Chowdhury TR, Sengupta MK, Chowdhury UK, Lodh D, Chanda CR, Basu GK, Mukherjee SC, Saha KC, Chakrabarti D.. Arsenic groundwater contamination and sufferings of people in north 24-parganas, one of the nine arsenic affected districts of West Bengal, India. J Environ Sci Health Part A 2003;38:25-59.
7. Navas-Acien A, Sharrett AR, Silbergeld EK, Schwartz BS, Nachman KE, Burke TA, Gualiar E. Arsenic exposure and cardiovascular disease: a systematic review of the epidemiologic evidence. Am J Epidemiol 2005;162:1037-49.
8. Wang CH, Hsiao CK, Chen CL, Hsu LI, Chiou HY, Chen SY, Hsueh YM, Wu MM, Chen CJ. A review of the epidemiologic literature on the role of environmental arsenic exposure and cardiovascular diseases. Toxicol Appl Pharmacol 2007;222:315-26.
9. Santra A, Maiti A, Chowdhury A, Guha Mazumder DN. Oxidative stress in liver of mice exposed to arsenic-contaminated water. Ind J Gastroenterol 2000;19:112-15.
10. Aposhian HV. Enzymatic methylation of arsenic species and other new approaches to arsenic toxicity. Annu Rev Pharmacol Toxicol 1997;27:397-419.
11. Boyer JL. Arsenic: an endothelial cell toxin in the liver Ind J Gastroenterol 1999;18:141-2.
12. Beres J. Interactive relations between Cu, FC, Zn, as, Cd & Pb in the liver in sheep after experimental poisoning with copper oxide. Vet Med Praka 1989;34:665-74.
13. Ghosh A, Ghatak S, Datta S, Dhali GK, Choudhury A, Santra A. Dimethyl arsenic acid induced apoptosis of hepatocytes is mediated through mitochondria. An Vitro Study. Ind J Gastroenterol 2007;26:4-87.
14. Dizik M, Christmas JK, Wenaton E. Alternatives in expression and methylation of specific genes in livers of rats fed a cancer promoting methyl deficient diet. Carcinogenesis 1991;12: 1303-12.
15. Zapisek WF, Cronin GM, Lyn-Cook BD, Poirier LA. The onset of oncogene hypomethylation in the livers of rats fed methyl-deficient, amino acid-defined diets. Carcinogenesis 1992;13: 1869-72.
16. Mueller PD, Benowitz NL. Toxicologic causes of acute abdominal disorders. Emerg Med Clin North Am 1989;7:667-82.
17. Maillard MP, Perregaux C, Centeno C, Stangier J, Wienen W, Brunner HR, Burnier M. In vitro and in vivo characterization of the activity of telmisartan: an insurmountable angiotensin ii receptor antagonist. J Pharmacol Exp Ther 2002;302:1089-95.
18. Fukuda D, Enomoto S, Hirata Y, Nagai R, Sata M. The angiotensin receptor blocker, telmisartan, reduces and stabilizes atherosclerosis in ApoE and AT1aR double deficient mice. Biomed Pharmacother 2010;64:712-17.
19. Fukuda D, Sata M. Expanded roles of the renin-Angiotensin system. Hypertens Res 2013;36:586-7.
20. Ono Y, Nakaya Y, Bando S, Soeki T, Ito S, Sata M. Telmisartan decreases plasma levels of asymmetrical dimethyl-l-Arginine and improves lipid and glucose metabolism and vascular function. Int Heart J 2009;50:73-83
21. Esposito K, Marfella R, Ciotola M, Di Palo C, Giugliano F, Giugliano G, D'Armiento M, D'Andrea F, Giugliano D. Effect of a Mediterranean-style diet on endothelial dysfunction and markers of vascular inflammation in the metabolic syndrome: a randomized trial. J Am Med Assoc 2004;292:1440-6.
22. Estruch R, Martínez-González MA, Corella D, Salas-Salvadó J, Ruiz-Gutiérrez V, Covas MI, Fiol M, Gómez-Gracia E, López-Sabater MC, Vinyoles E, Arós F, Conde M, Lahoz C, Lapetra J, Sáez G, Ros E. Effects of a Mediterranean-style diet on cardiovascular risk factors a randomized trial. Ann Intern Med 2006;145:1-11.
23. Din JN, Newby DE, Flapan AD. Omega 3 fatty acids and cardiovascular disease fishing for a natural treatment. BMJ 2004;328:30-5.
24. Mittra S, Singh M. Possible mechanism of captopril induced endothelium-dependent relaxation in isolated rabbit aorta. Mol Cell Biochem 1998;183:63-7.
25. Song D, Arikawa E, Galipeau DM, Yeh JH, Battell ML, Yuen VG, McNeill JH Chronic estrogen treatment modifies insulin-induced insulin resistance and hypertension in ovariectomized rats. Am J Hypertens 2005;18:1189-94.
26. Wong CM, Yao X, Au CL, Tsang SY, Fung KP, Laher I, Vanhoutte PM, Huang Y. Raloxifene prevents endothelial dysfunction in aging ovariectomized female rats. Vasc Pharmacol 2006;44: 290-8.
27. Ma FX, Liu LY, Xiong XM. Protective effects of lovastatin on vascular endothelium injured by low density lipoprotein. Acta Pharmacol Sin 2003;24:1027-32.
28. Misra HP, Fridovich I. The role of superoxide anion in the autoxidation of epinephrine and a simple assay for superoxide dismutase. J Biol Chem 1972;247:3170-5.
29. Moron MS, Depierre JW, Mannervik B. Levels of glutathione, glutathione reductase and glutathione S-transferase activities in rat lung and liver. Biochim Biophys Acta 1979;582:67-78.
30. Cortas NK, Wakid NW. Determination of inorganic nitrate in serum and urine by a kinetic cadmium-reduction method. Clin Chem 1990;36:1440-3.
31. Allain CC, Poon LS, Chen CS, Richmond W, Fu PC. Enzymatic determination of total serum cholesterol. Clin Chem 1974;20:470-5.
32. McGowan MW, Artiss JD, Strandbergh DR, Zak B. A peroxidasecoupled method for the colorimetric determination of serum triglycerides. Clin Chem 1983;29:538-42.
33. Anderson TJ, Uehata A, Gerhard MD, Meredith IT, Knab S, Delagrange D, Lieberman EH, Ganz P, Creager MA, Yeung AC. Close relation of endothelial function in the human coronary and peripheral circulations. J Am Coll Cardiol 1995;26:1235-41
34. Kinlay S, Ganz P. Role of endothelial dysfunction in coronary artery disease and implications for therapy. Am J Cardiol 1997;80:11-I-16-I.
35. Ambring A, Friberg P, Axelsen M, Laffrenzen M, Taskinen MR, Basu S, Johansson M. Effects of a Mediterranean-inspired diet on blood lipids, vascular function and oxidative stress in healthy subjects. Clin Sci 2004;106:519-26.
36. Varady KA, Bhutani S, Klempel MC, Phillips SA. Improvements in vascular health by a low-fat diet, but not a high-fat diet, are mediated by changes in adipocyte biology. Nutr J 2011;10:8.
37. Spence JD. Importance of diet in vascular prevention: vastly underestimated. Circulation 2002;106:e133.
38. Kris-Etherton PM, Harris WS, Appel LJ. Fish consumption, fish oil, omega-3 fatty acids, and cardiovascular disease. Circulation 2002;106:2747-57.
39. Chung JY, Yu SD, Hong YS. Environmental source of arsenic exposure. J Prev Med Public Health 2014;47:253-7.
40. Singh AP, Goel RK, Kaur T. Mechanisms pertaining to arsenic toxicity. Toxicol Int 2011;18:87-93.
41. Haghighi MK, Pollock D. The possible involvement of nitric oxide/endothelium derived relaxing factor in atropine-induced vasorelaxation. Iran Biomed J 2001;5:133-9.
42. Stiuso P, Scognamiglio I, Murolo M, Ferranti P, De Simone C, Rizzo MR, Concetta T, Caraglia M, Federico, A. Serum oxidative stress markers and lipidomic profile to detect NASH patients responsive to an antioxidant treatment: a pilot study. Oxid Med Cell Longev 2014;1-8.
43. Dursun B, Dursun E, Suleymanlar G, Ozben B, Capraz I, Apaydin A, Ozben T. Carotid artery intima-media thickness correlates with oxidative stress in chronic haemodialysis patients with accelerated atherosclerosis. Nephrol Dial Transplant 2008;23:1697-703.
44. Padovani AM, Molina MF, Mann KK. Inhibition of liver x receptor/retinoid x receptor-mediated transcription contributes to the proatherogenic effects of arsenic in macrophages in vitro. Arterioscler Thromb Vasc Biol 2010;30:1228-36.
45. Benson SC, Pershadsingh HA, Ho CI, Chittiboyina A, Desai P, Pravenec M, Qi N, Wang J, Avery MA, Kurtz TW. Identification of telmisartan as a unique angiotensin II receptor antagonist with selective PPARgamma-modulating activity. Hypertension 2004;43:993-1002.
46. Calder PC. N-3 fatty acids and cardiovascular disease: evidence explained and mechanisms explored. Clin Sci 2004;107:1-11.
47. Grossini E, Molinari C, Caimmi PP, Uberti F, Vacca G. Levosimendan induces NO production through P38 MAPK, ERK and Akt in porcine coronary endothelial cells: role for mitochondrial K(ATP) channel. Br J Pharmacol 2009;156:250-61.
48. Zong F, Zuo XR, Wang Q, Zhang SJ, Xie WP, Wang H. Iptakalim rescues human pulmonary artery endothelial cells from hypoxia-induced nitric oxide system dysfunction. Exp Ther Med 2012;3:535-9.
49. Kaur J, Reddy K, Balakumar P. The novel role of fenofibrate in preventing nicotine and sodium arsenite-induced vascular endothelial dysfunction in the rat. Cardiovasc Toxicol 2010;10:227-38.
50. Tomai F, Crea F, Gaspardone A, Versaci F, De Paulis R, de Peppo AP, Chiariello L, Gioffré PA. Ischemic preconditioning during coronary angioplasty is prevented by glibenclamide, a selective ATP-sensitive K+ channel blocker. Circulation 1994;90:700-5.